Neoadjuvant PD-1 blockade plus chemotherapy induces a high pathological complete response rate and anti-tumor immune subsets in clinical stage III gastric cancer

Volume 11, Issue 1, December 2022 .
Source: OncoImmunology - Category: Cancer & Oncology Authors: Source Type: research